Clinical trial
Individual beta2-adrenergic Performance Response to Salbutamol
NCT04615611 is registered in ClinicalTrials.gov with University of Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Individual beta2-adrenergic Performance Response to Salbutamol
- Lead sponsor
- University of Copenhagen
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 7, 2020
- Completion date
- November 7, 2021
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
healthy